Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FJN30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,814
Award facts
- Contract value 100% obligated
- $29,813.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Opdivo 240 mg/24 ml vials with a ceiling value of $29,813.58. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The contract is set to be completed by September 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. Opdivo is a critical immunotherapy medication used in cancer treatment, reflecting the Defense Logistics Agency's ongoing need to maintain pharmaceutical inventories for military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts and serves critical healthcare customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal procurement requirements through open competition on diverse pharmaceutical products positions it as a key vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FJN30?
SPE2DB25FJN30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FJN30 worth?
The government has obligated $29,814 on SPE2DB25FJN30.
Is contract SPE2DB25FJN30 an order under another contract?
Yes. SPE2DB25FJN30 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJN30 competed?
The extent of competition for SPE2DB25FJN30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award